These tumor-associated neutrophils (TANs) have the potential to suppress the anti-tumor activities of tumor-specific infiltrating lymphocytes (TILs) of the CD4+ Th1 and cytotoxic CD8+ phenotypes, as well as driving angiogenesis and metastasis. The gene discussed is CD8A; the disease is neoplasm.